Industrial Alliance Investment Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-18,130
Closed -$2.52M 202
2023
Q1
$2.52M Buy
18,130
+438
+2% +$58.9K 0.07% 203
2022
Q4
$2.4M Sell
17,692
-39,139
-69% -$4.91M 0.07% 211
2022
Q3
$6.23M Buy
56,831
+7,363
+15% +$934K 0.18% 123
2022
Q2
$6.54M Buy
49,468
+570
+1% +$74.8K 0.19% 120
2022
Q1
$6.49M Buy
48,898
+5,813
+13% +$697K 0.15% 141
2021
Q4
$5.02M Buy
+43,085
New +$5.07M 0.12% 164

Other funds holding AZN

Industrial Alliance Investment Management's AZN Position: Q2 2023 in Review

Industrial Alliance Investment Management sold out of AstraZeneca (AZN) in Q2 2023, closing a stake of 18,130 shares — an estimated $2.52M sold.

Industrial Alliance Investment Management first reported a position in AZN in Q4 2021 and held it in 6 quarters. The position peaked at $6.54M in Q2 2022. 1,092 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

  • Industrial Alliance Investment Management reported no remaining AstraZeneca position as of Q2 2023 after selling out during the quarter.
  • Industrial Alliance Investment Management sold 18,130 AstraZeneca shares in Q2 2023, an estimated $2.52M.
  • Industrial Alliance Investment Management first reported a position in AstraZeneca in Q4 2021 and held it in 6 quarters.
  • Industrial Alliance Investment Management's AstraZeneca position peaked at $6.54M in Q2 2022.
  • 1,092 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on Industrial Alliance Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.